Vivani Medical (VANI) Total Liabilities (2014 - 2026)
Vivani Medical (VANI) posted quarterly Total Liabilities of $23.3 million for Q1 2026, down 2.35% year-over-year from $23.8 million in Q1 2025, and down 1.67% quarter-over-quarter from $23.7 million in Q4 2025.
Vivani Medical (VANI) Total Liabilities (2014 - 2026) Analysis & Trends
Vivani Medical's Total Liabilities history runs 13 years deep, the most recent figure standing at $23.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 2.35% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $23.3 million (down 2.35% YoY), while the FY2025 annual figure was $23.7 million, down 1.2% from the prior year.
- Total Liabilities for Q1 2026 stood at $23.3 million, down from $23.7 million in the prior quarter.
- The five-year high for Total Liabilities was $27.2 million in Q2 2023, with the low at $2.4 million in Q1 2022.
- The 5-year median for Total Liabilities is $23.8 million (2025), against an average of $18.8 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 66.59% in 2022, then jumped 950.29% in 2023.
- Vivani Medical's Total Liabilities stood at $6.8 million in 2022, then surged by 266.99% to $25.0 million in 2023, then retreated by 4.33% to $24.0 million in 2024, then declined by 1.2% to $23.7 million in 2025, then retreated by 1.67% to $23.3 million in 2026.
- Business Quant data shows VANI's Total Liabilities at $23.3 million in Q1 2026, $23.7 million in Q4 2025, and $23.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 22.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.67 Mn |
| Mar 31, 2026 | 23.27 Mn |
| Dec 31, 2025 | 23.66 Mn |
| Sep 30, 2025 | 23.74 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 23.83 Mn |
| Dec 31, 2024 | 23.95 Mn |
| Sep 30, 2024 | 24.56 Mn |
| Jun 30, 2024 | 24.40 Mn |
| Mar 31, 2024 | 25.08 Mn |
| Dec 31, 2023 | 25.04 Mn |
| Sep 30, 2023 | 27.11 Mn |
| Jun 30, 2023 | 27.21 Mn |
| Mar 31, 2023 | 6.21 Mn |
| Dec 31, 2022 | 6.82 Mn |
| Sep 30, 2022 | 5.66 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 4.02 Mn |